About Juvenescence
Juvenescence is a company based in Dublin (Ireland) founded in 2017 by Greg Bailey.. Juvenescence has raised $289.89 million across 7 funding rounds from investors including M42, Fastforward Innovations and IDO Investments. Juvenescence has completed 1 acquisition, including Ro5. Juvenescence offers products and services including Aging Medicines and AI-Enabled R&D Tools. Juvenescence operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Dublin, Ireland
- Founders Greg Bailey
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Juvenescence
Juvenescence offers a comprehensive portfolio of products and services, including Aging Medicines and AI-Enabled R&D Tools. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medicines targeting core aging processes for disease prevention.
Tools integrating AI to design and accelerate drug development.
Unlock access to complete
Unlock access to complete
Funding Insights of Juvenescence
Juvenescence has successfully raised a total of $289.89M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $76 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $76.0M
-
First Round
First Round
(06 Dec 2017)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series B - Juvenescence | Valuation |
investors |
|
| Sep, 2019 | Amount | Series B - Juvenescence | Valuation | IDO Investments |
|
| Aug, 2019 | Amount | Series B - Juvenescence | Valuation | Grok Ventures , Ipgl |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Juvenescence
Juvenescence has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include M42, Fastforward Innovations and IDO Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are targeted for investments by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Early-late stage tech-focused venture capital firm
|
Founded Year | Domain | Location | |
|
Tech & life Science focused early stage VC firm investing in North America & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Juvenescence
Juvenescence has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Ro5. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-based drug discovery management tool is provided for researchers.
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Juvenescence
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Juvenescence Comparisons
Competitors of Juvenescence
Juvenescence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Juvenescence
Frequently Asked Questions about Juvenescence
When was Juvenescence founded?
Juvenescence was founded in 2017.
Where is Juvenescence located?
Juvenescence is headquartered in Dublin, Ireland.
Who is the current CEO of Juvenescence?
Greg Bailey is the current CEO of Juvenescence. They have also founded this company.
Is Juvenescence a funded company?
Juvenescence is a funded company, having raised a total of $289.89M across 7 funding rounds to date. The company's 1st funding round was a Series B of $100M, raised on Dec 06, 2017.
What does Juvenescence do?
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health. The company offers keto-diet-based exogenous ketone which helps in metabolic switches and provides anti-aging properties and protection from other age-related diseases like neurodegenerative diseases, immunosenescence cell damage. The product is C6 Ketone Di-Ester which can raise the levels of ketones in the blood to generate ketosis.
Who are the top competitors of Juvenescence?
Juvenescence's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Juvenescence offer?
Juvenescence offers Aging Medicines and AI-Enabled R&D Tools.
How many acquisitions has Juvenescence made?
Juvenescence has made 1 acquisition, including Ro5.
Who are Juvenescence's investors?
Juvenescence has 8 investors. Key investors include M42, Fastforward Innovations, IDO Investments, Grok Ventures, and Ipgl.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.